AbCellera Biologics Inc.

ABCL Q1 2026

Reported: 2026-05-13

Shares declined 5.7% as investors reacted negatively to cautious outlook signals embedded in the update, notably the absence of new guidance and limited visibility on upcoming catalysts despite the Phase I data release.

Key takeaways

ABCL635 advanced to Phase II based on encouraging interim Phase I safety and pharmacokinetic data, with no serious adverse events or liver toxicity reported.
The Phase I trial included 40 healthy volunteers across single ascending dose cohorts; multiple ascending dose data remain blinded and pending.
Management emphasized upcoming key catalysts in 2026, including top line data for ABCL635 in Q3 and pipeline advancement activities, but provided no updated financial guidance.
The stock’s down move likely reflects investor disappointment in lack of new forward-looking clarity and incremental nature of the disclosed data.
No commentary on revenue or margin trends was given, underscoring limited near-term visibility on financial performance.

View recap

AECOM

ACM Q2 2026

Reported: 2026-05-13

AECOM shares declined 12.0% post-earnings, reflecting investor disappointment likely driven by emerging deceleration risks in key international transportation markets and lingering uncertainty related to the Middle East outlook, despite record backlog and raised profit guidance.

Key takeaways

Backlog reached a record high, up 8%, supported by a book-to-burn ratio of 1.2x, underpinning revenue visibility.
Americas design segment, the most profitable, grew NSR by 8% and expanded segment operating margin by 50 basis points to 16.5%.
Strong U.S. funding environments persist, with over half of IIJA funds remaining and a 50% pipeline increase in defense work, supporting growth.
International segment growth was mixed: the UK saw a return to growth in water and energy, but transportation demand remains weak.
The outlook was tempered by Middle East conflicts, introducing uncertainty despite the company raising full-year profit guidance for adjusted EBITDA and EPS by 7% and 14%, respectively.

View recap

First Majestic Silver Corp.

AG Q1 2026

Reported: 2026-05-13

First Majestic Silver’s shares rose modestly by 2.7% following Q1 results that showed production and revenues largely in line with guidance, supported by strong silver prices, while margin expansion and cost pressures balanced each other out.

Key takeaways

Q1 silver production was 3.5 million ounces, representing 26% of 2026 midpoint guidance; gold production was 28% of midpoint guidance.
Average realized silver price surged to $86.35 from $33.10 in Q1 2025, driving record revenues of $477 million, up 95% year over year.
The company held back 676,000 ounces of silver and 2,700 ounces of gold in inventory valued at $63 million, foregoing near-term revenue for expected higher prices.
Operating cash flow reached $311 million ($0.63 per share), reflecting solid cash generation despite slightly higher production costs due to lower cut-off grades and increased throughput.
Dividend payout increased fourfold versus last year, reflecting a shift in policy from 1% to 2% of revenue and signaling confidence in cash flow stability.

View recap

Adecoagro S.A.

AGRO Q1 2026

Reported: 2026-05-13

Adecoagro's shares edged up modestly by 1.2% following Q1 results that showed solid operational progress, notably in fertilizer production and ethanol output, but lacked a clear catalyst for a stronger market response. The measured market reaction suggests investors are awaiting clearer evidence of sustained margin expansion or updated guidance before rewarding the stock more aggressively.

Key takeaways

Adjusted EBITDA more than doubled year-over-year to $86 million, reflecting contributions from all three reportable segments under the new organizational structure.
Sugar, Ethanol and Energy segment delivered a first quarter crushing record of 2.2 million tons (+49% YoY) with 96% ethanol production mix, capitalizing on favorable ethanol pricing despite lower sugar sales.
Fertilizer segment saw a 68% increase in urea sales driven by 16% higher prices and improved operational uptime after maintenance, with the plant now running at full capacity.
Agricultural costs rose due to Brazilian real appreciation and an accelerated timing of expenses, partially offsetting cost dilution from higher crushing volumes.
Management reiterated expectations for continued growth in crushing volumes and further upside in fertilizer earnings, supported by geopolitical price pressure on urea amid Middle East conflict.

View recap

a.k.a. Brands Holding Corp.

AKA Q1 2026

Reported: 2026-05-13

a.k.a. Brands shares rose 3.9% following a quarter marked by meaningful gross margin expansion and better-than-expected adjusted EBITDA, driven primarily by strong execution in the streetwear segment and effective inventory discipline.

Key takeaways

Net sales increased 3% to $132.5 million, reflecting steady top-line growth.
Adjusted EBITDA reached $5.1 million, beating expectations and indicating improved profitability.
Gross margin expanded approximately 180 basis points year-over-year to 59%, driven by inventory discipline, stronger full-price sell-through, and rollout of the test and repeat model, especially within streetwear brands.
Inventory was reduced by ~$45 million over three years, improving turns and enabling financial flexibility.
Omnichannel efforts, including wholesale, retail store openings, and marketplace expansions, are contributing to broader brand visibility and customer acquisition.

View recap

Amentum Holdings, Inc.

AMTM Q2 2026

Reported: 2026-05-13

Shares dropped 3.3% as investors reacted negatively to signs of margin pressure amid decelerating revenue growth and a cautious outlook despite record backlog growth and strong bookings.

Key takeaways

Revenue grew 3% on a normalized basis to $3.5 billion, showing slowing organic top-line momentum.
Adjusted EBITDA margin compressed to 7.9%, indicating margin pressure even as adjusted EPS rose 13% to $0.60.
Free cash flow remained solid at $220 million but lacked acceleration to offset margin concerns.
Net bookings totaled $4 billion with a healthy book-to-bill ratio of 1.2x; backlog hit a record $48 billion, up 7% year-over-year.
Management highlighted growth opportunities in nuclear, digital infrastructure, and space sectors, but a cautious tone on near-term outlook was evident.

View recap

Aramark

ARMK Q2 2026

Reported: 2026-05-13

Aramark’s shares rose 8.6% post-earnings, driven by better-than-expected organic revenue growth across U.S. and international segments, along with promising new business in the hyperscale AI data center market that is not yet reflected in fiscal 2026 guidance.

Key takeaways

Organic revenue grew 12% to $4.8 billion in Q2, including a 3% calendar shift benefit, with strong contributions from both U.S. and international operations.
U.S. Food Service & Support (FSS) organic revenue increased 12%, or approximately 8% excluding calendar impacts, supported by higher enrollments, sports events, and new client wins (e.g., Suffolk University, Toyota).
International segment delivered 13% organic revenue growth, led by double-digit increases in Europe and Canada and broad-based contributions across sectors and regions.
Management highlighted a multiyear contract with a top global hyperscale AI data center client, with associated new platform Aramark Nexus expected to generate above-average margins; however, this is not yet included in current full-year outlook.
Inflation and geopolitical risks remain, but supply chain scale and operational flexibility continue to help manage cost pressures.

View recap

Arvinas, Inc.

ARVN Q1 2026

Reported: 2026-05-13

Arvinas shares ticked up modestly by 2.2% following approval and licensing of VEPPANU but the market’s tepid response suggests investors remain cautious about near-term commercial execution and longer-term pipeline visibility.

Key takeaways

The FDA approved VEPPANU, the first PROTAC degrader approved for ESR1-mutant, ER+/HER2- advanced breast cancer, marking a milestone for Arvinas’ platform.
Arvinas licensed global commercialization, development, and manufacturing rights for VEPPANU to Rigel Pharmaceuticals, opting to focus internal resources on pipeline innovation.
Phase 1 data for ARV-102 in Parkinson’s disease demonstrated approximately 50% reductions in cerebrospinal fluid LRRK2 at day 14 sustained through day 28, alongside dose-dependent biomarker improvements with good tolerability.
The company maintains four ongoing Phase 1 clinical programs and a disciplined capital allocation approach but provided limited detail on near-term milestones or revenue guidance from VEPPANU.
The modest stock movement implies investor reservations on commercial visibility and execution risks despite scientific validation and platform progress.

View recap

Astronics Corporation

ATRO Q1 2026

Reported: 2026-05-13

Astronics rallied 3.3% after reporting revenue and bookings at the high end of guidance, driven by broad demand and margin expansion. Investors responded positively to improved profitability and an upward revision to full-year revenue guidance reflecting strong order momentum.

Key takeaways

Q1 revenue of $231 million marked a 12% increase year-over-year and was near the top of the guided range.
Adjusted EBITDA margin expanded to 16.4% from 14.9% a year ago, reflecting volume leverage, productivity improvements, and a favorable MV-75 program catch-up.
Bookings hit a record $290 million, with a book-to-bill ratio of 1.26, supporting backlog growth to a new high of $734 million.
Full-year revenue guidance was raised to $970 million–$1 billion, implying 14% organic growth at the midpoint.
Despite margin gains, tariff costs increased by $1.7 million, partially offsetting benefits from operational improvements.

View recap

Camtek Ltd.

CAMT Q1 2026

Reported: 2026-05-13

Camtek's stock fell sharply by 18.6% following its earnings report, driven primarily by cautious guidance and signs of operating margin pressure despite solid revenue growth and record order intake.

Key takeaways

First-quarter revenue reached $121.7 million, slightly ahead of prior-year quarter but showed no clear acceleration.
Gross margin held steady at 51%, with expectations of improvement later in the year tied to product mix shifts, but operating expenses rose notably to $30.9 million from $24.4 million a year ago.
Operating income declined to $31.1 million from $37.3 million in Q1 2025, signaling margin compression and cost pressures.
Management expressed confidence in a strong second half of 2026, banking on a 25% revenue increase and doubling revenue from new AI-driven platforms, yet market reaction suggests skepticism over near-term execution and outlook.
Despite positive commentary on AI-related product adoption and backlog strength, the cautious tone on expenses, flat sequential operating income, and lack of explicit upward revisions to near-term guidance weighed heavily on investor sentiment.

View recap

Consolidated Water Co. Ltd.

CWCO Q1 2026

Reported: 2026-05-13

Shares declined 7.7% following weaker-than-expected revenue driven by a steep 76% drop in manufacturing sales and a 10% volume decline in retail water sales, reflecting deceleration and margin pressure in key segments. Despite growth in bulk and services, investors were clearly disappointed by lowered segment performance and cautious commentary on manufacturing prospects.

Key takeaways

Total Q1 revenue declined 11% to $30 million, led by a $4.4 million (76%) drop in manufacturing revenue due to project timing and fewer new purchase orders.
Retail segment revenue fell by $834,000, driven by a 10.2% decrease in water volume sold in Grand Cayman amid wetter weather conditions, partially offset by record tourism growth.
Bulk and services segments saw modest revenue increases of $333,000 and $1.2 million respectively; service revenue grew 15% driven by new and expanded O&M contracts.
Gross profit margin contracted slightly to 36% from 37% a year ago, reflecting declines in higher-margin manufacturing and retail sales.
Accounts receivable for the CW-Bahamas operations rose, adding uncertainty around collection timelines despite government assurances. Cash and liquidity remain strong, with no significant debt and ongoing capital expenditures planned.

View recap

Danaos Corporation

DAC Q1 2026

Reported: 2026-05-13

Danaos shares declined 0.7% following the quarterly report, reflecting investor caution despite modest earnings gains, driven by continued pressures from lower containership charter rates and non-cash revenue recognition headwinds.

Key takeaways

Adjusted EPS rose to $6.72 from $6.04 year-over-year, with adjusted net income improving by $9.1 million to $122.5 million.
Containership segment revenues fell by $6.6 million due to lower contracted charter rates and a $7.2 million non-cash U.S. GAAP revenue recognition impact, partially offset by fleet additions and better utilization.
Dry bulk fleet revenues increased $7 million, supported by a jump in time charter equivalent earnings to $24,825 per day from roughly $10,500.
Operating expenses were reduced by $4.4 million overall, including vessel operating cost improvements despite fleet expansion.
Interest expense rose by $1.7 million on higher average debt levels, partially offset by improved interest income from higher cash balances.

View recap

Ducommun Incorporated

DCO Q1 2026

Reported: 2026-05-13

Ducommun’s shares gained 3.1% as commercial aerospace rebounded sharply with 18% revenue growth and defense bookings remain robust, underpinning visibility and positioning for future growth.

Key takeaways

Q1 revenue hit a record $209 million, up 9% year-over-year, marking the 20th consecutive quarter of revenue growth.
Commercial aerospace drove the quarter’s improvement with 18% sales growth, supported by higher OEM production rates and less destocking than expected.
Defense backlog remains strong at nearly $1.1 billion RPO, up $86 million from last year, with a book-to-bill ratio of 1.2 over 12 months.
Closed $175 million in bookings for Q1 and $925 million over the past 12 months, with additional potential upside from missile program framework agreements currently under negotiation.
Gross and adjusted EBITDA margins are tracking well against Vision 2027 goals, indicating operational discipline amid growth.

View recap

3D Systems Corporation

DDD Q1 2026

Reported: 2026-05-13

Shares surged 23.9% post-earnings, reflecting strong growth in printer, parts, and healthcare materials sales, with industry-leading product innovation and expanding addressable markets driving investor enthusiasm.

Key takeaways

Double-digit year-over-year growth in printer sales and materials across healthcare and industrial segments.
Momentum in medical parts manufacturing, particularly titanium spinal and cobalt chrome joint implants, fueled growth despite a temporary disruption at a key customer.
Dental material sales advanced strongly, supported by increased demand for aligners and prosthetic materials under the Vertex brand, now expanded in the U.S. market after regulatory approval.
Successful launch of NextDent 300 denture printing system with early commercial traction, including major deployment by ROE Dental Labs tripling their manufacturing capacity.
Regulatory milestones achieved ahead of schedule, expanding total addressable market to over 60 million edentulous patients globally with multibillion-dollar digital dentistry opportunity.

View recap

Electromed, Inc.

ELMD Q3 2026

Reported: 2026-05-13

Electromed’s Q3 results surpassed expectations, driving a 31.2% stock rally, powered by broad-based revenue growth, significant margin expansion, and strong execution in both commercial and clinical initiatives.

Key takeaways

Revenue grew 18.4% year-over-year to $18.6 million, supported by a 19% increase in Home Care and a 43% rebound in Hospital sales.
Operating income surged 76% to $3.8 million, reflecting meaningful margin improvement.
Diluted EPS rose 67% to $0.35, marking continued profitability gains.
The company advanced adoption with over 40% of orders through its Smart Order ePrescribe system, shortening shipment times by 5 days.
Clinical education efforts and the Triple Down on Bronchiectasis campaign are driving awareness in a large underpenetrated patient market.

View recap

eToro Group Ltd.

ETOR Q1 2026

Reported: 2026-05-13

Shares fell 2.9% as investors appeared cautious despite solid growth, likely due to a lack of incremental upside or concerns about margin pressure and cautious outlook given the absence of explicit guidance acceleration or margin commentary.

Key takeaways

Net contribution rose 19% year-over-year to $258 million, while adjusted EBITDA increased 35% to $109 million, marking new company records.
Funded accounts grew 12% year-over-year to over 4 million, representing the fastest organic growth in over a year, supported by increased marketing and improved retention.
Assets under administration expanded 15% year-over-year to $17 billion, driven by strong customer inflows.
Commodities trading volumes surged nearly fourfold year-over-year, now accounting for 60% of trading commissions, reflecting shifts from crypto and equities.
The company emphasized AI adoption across all functions, accelerating product development and operational productivity, though no concrete financial impact was quantified.

View recap

Figure Technology Solutions, Inc. Class A Common Stock

FIGR Q1 2026

Reported: 2026-05-13

Figure Technology's shares rose modestly by 1.4% following Q1 2026 results, reflecting a largely in-line performance with no material surprises to drive the stock more meaningfully in either direction.

Key takeaways

The company continues to build its blockchain-native capital market ecosystem spanning debt and structured finance, equity and non-debt digital assets, and capital and financing markets.
Majority of mortgage production now comes through 380+ third-party partners, with over half trading on the Connect whole loan marketplace.
Forge platform facilitates liquidity by transforming whole loans into small liquid participation units, enabling DeFi collateralization and market arbitrage.
Launched OPEN, an on-chain public equity network offering 24/7 trading, wallet self-custody, and direct DeFi borrowing/lending benefits for shareholders.
The business model centers on marketplace operation, DeFi bridging, and arbitrage participation, but management highlighted ongoing development and scaling rather than delivering updated guidance or quantifiable financial beats.

View recap

Fold Holdings Inc

FLD Q1 2026

Reported: 2026-05-13

Fold’s shares edged up 0.7% post-earnings, reflecting a largely steady reaction as investors digest early product launches and ongoing structural initiatives amidst broader Bitcoin market headwinds.

Key takeaways

Bitcoin price weakness pressured transaction volumes and consumer engagement in the quarter, consistent with industry trends.
The Fold Credit Card launched in early access with over 1,000 cardholders and a waitlist exceeding 8,000, but did not materially contribute to Q1 financials given its phased rollout.
Early credit card user behavior indicates meaningful engagement across Fold’s ecosystem, including high spend in both everyday and major purchase categories.
The Bitcoin Gift Card segment continues to onboard new customers and drive re-engagement, supported by a successful Kroger partnership and ongoing retailer expansion efforts.
Fold introduced a Bitcoin bonus program with Steak ‘n Shake to broaden its business-facing platform, targeting employee savings and retention rather than speculative trading.

View recap

Fractyl Health, Inc. Common Stock

GUTS Q1 2026

Reported: 2026-05-13

Shares fell 4.6% as investors reacted to cautious outlook signals, including slower-than-expected momentum in the pivotal trial enrollment and an extended timeline to top-line data, raising concerns about near-term value realization.

Key takeaways

The pivotal REMAIN-1 trial completed randomization in February with over 300 participants across 30+ U.S. sites, but the market appears concerned about the pace and timing of data readout.
Co-primary endpoints focus on mitigating weight regain at 6 months post-tirzepatide discontinuation and maintaining ≥5% weight loss at 52 weeks; top-line results are expected in early Q4 2026.
Participant retention remains high (>90%), and adverse events align with prior studies, supporting trial continuity but offering no immediate upside.
Management reaffirmed no planned capital raise before pivotal data, yet the extended timeline limits visibility on near-term catalysts.
FDA feedback continues to favor a moderate-risk device classification, with submission anticipated late Q4 2026 contingent on the 6-month data.

View recap

Hims & Hers Health, Inc.

HIMS Q1 2026

Reported: 2026-05-13

Shares dropped 11.5% following earnings as investors reacted negatively to a cautious outlook on growth and margin pressures despite commentary on platform expansion and new product introductions.

Key takeaways

Management highlighted progress in expanding therapeutic specialties and strategic initiatives, including a shift in the weight loss business towards a broader, globally unified approach.
Adoption of GLP-1 products, including over 125,000 shipments of Wegovy within six weeks, showed initial demand strength but did not offset broader investor concerns.
Expansion efforts include a planned acquisition of Eucalyptus to enhance global footprint across key markets like Australia, the U.K., Germany, Japan, and Canada.
The company emphasized investments in data and technology, aiming for longer-term platform engagement and network effects.
Despite these positives, investor reaction suggests skepticism about near-term growth acceleration and margin sustainability, as reflected in the significant decline in share price.

View recap

NIC Inc.

HLIT Q1 2026

Reported: 2026-05-13

Harmonic's shares rose modestly by 0.9% following earnings, reflecting a quarter in line with expectations that showed solid broadband revenue growth and backlog expansion but without a meaningful market surprise.

Key takeaways

Q1 broadband revenue grew 43% year-over-year to $121.7 million, driven largely by rest of market demand representing 42% of total broadband revenue.
Backlog and deferred revenue increased 87% year-over-year, improving visibility into future sales.
Fiber products now account for over 14% of appliance and integration revenue and continue to gain traction with multiple new wins, including international deployments.
DOCSIS 4.0 adoption expanded with new customers and ongoing deployments, supporting upstream capacity growth of about 20% annually at a leading operator.
Management reiterated progress on the pending sale of the video business, aiming to finalize in Q2 to further focus on broadband.

View recap

Harrow Health, Inc.

HROW Q1 2026

Reported: 2026-05-13

Shares fell sharply by 21.6% as investors were disappointed by a significant $8 million revenue reduction tied to VEVYE, reflecting an unforeseen deceleration in a key product's financial contribution and cautious near-term revenue outlook despite management’s assertions of strong demand.

Key takeaways

Reported revenue was notably impacted by an $8 million reduction specifically attributed to VEVYE, due to patient utilization patterns that outpaced initial models.
While demand trends for key growth drivers (VEVYE, IHEEZO, and TRIESENCE) were described as accelerating and market share gains continued, these did not translate into the financial results investors anticipated this quarter.
The company implemented pricing corrections and new business rules expected to stabilize revenue and realize benefits starting in Q2, indicating prior quarter weakness.
Investments into commercial scaling were completed, including doubling the sales force, positioning the company for improved demand conversion and longer-term growth.
Management emphasized operational fixes can mitigate problems, but the recent revenue miss underscores that correcting demand and financial capture challenges remains critical.

View recap

HUYA Inc.

HUYA Q1 2026

Reported: 2026-05-13

HUYA’s shares dropped 5.8% as investors reacted negatively to cautious outlook signals overshadowing solid revenue growth, reflecting concerns about margin pressure and deceleration in more mature segments.

Key takeaways

Total net revenues increased 15% year-over-year to RMB 1.73 billion, driven by strong growth in game-related services, advertising, and other businesses (RMB 627 million, +69% YoY).
Live streaming revenues remained robust at RMB 1.1 billion, supported by diversified content and external platform reach doubling to over 200 million users.
Notable success in game publishing with Goose Goose Duck mobile achieving #1 on iOS free game charts and entering the top 5 grossing games in April, yet monetization remains nascent and gradual.
Advertising campaigns showed effectiveness with several high-profile partnerships but ongoing investment in content and tournaments likely weighing on margins.
Despite growth initiatives, the market appears wary of HUYA’s ability to sustain momentum given intensified competition and a cautious outlook on near-term profitability and segment maturation.

View recap

Imperial Brands PLC

IMB.L Q2 2026

Reported: 2026-05-13

The stock gained 3.8% following the earnings report, reflecting investor approval of solid pricing-driven tobacco revenue growth and positive strategic progress, despite some one-off headwinds and below-guidance NGP revenue growth.

Key takeaways

Tobacco net revenue grew in low single digits, driven by strong pricing that more than offset volume declines across key regions: Europe (+6% pricing), U.S. (+5.7%), and AAACE excluding Australia (+6.1%).
Adjusted operating profit increased modestly by 0.6%, pressured by one-offs in the U.S. and Australia and reduced profit from tobacco inventory at [La Hista].
NGP revenue growth was below guidance due to timing of U.S. promotions, which negatively affected half 1 results by ~GBP 13 million, although underlying NGP revenue excluding these factors would have shown double-digit growth and reduced losses.
Free cash flow remained robust at GBP 2.6 billion over 12 months, with leverage steady year-on-year at 2.4x, supporting ongoing capital returns including a 4% dividend increase and EUR 1.45 billion share buyback.
Management reaffirmed full-year guidance and emphasized strategic transformation actions that deliver cost efficiencies and build long-term growth capabilities.

View recap

Imunon Inc. Common Stock

IMNN Q1 2026

Reported: 2026-05-13

IMUNON's shares declined 4.8% following the quarter as investors reacted negatively to a cautious outlook centered on the lengthy timeline to full enrollment and data maturation for the pivotal Phase III OVATION 3 study, compounded by the challenging capital funding environment and the need for incremental financing that could pressure dilution.

Key takeaways

Phase III trial enrollment (OVATION 3) progressing but expected to take significant time to reach 500 patients and generate mature survival data required for BLA filing.
Phase II data showed a median overall survival benefit of 14.7 months with IMNN-001 plus standard chemotherapy, but Phase III results remain pending with data maturity timeline weighing on investor sentiment.
Management flagged a challenging biotech capital environment and plans to raise bridge financing that aims to minimize dilution but still presents risk to shareholder equity.
Safety and preliminary clinical data remain consistent and favorable, supporting confidence in the IMNN-001 program’s scientific profile.
Planned R&D Day in Q3 2026 intended to deepen investor understanding, but tangible progress and readouts are still some time away.

View recap

IZEA Worldwide, Inc.

IZEA Q1 2026

Reported: 2026-05-13

IZEA's shares declined 5.0% after the quarter, reflecting investor disappointment with revenue deceleration driven by the ongoing exit from lower-margin SMB accounts and a cautious near-term outlook despite progress on the strategic shift to enterprise clients.

Key takeaways

Revenue declined to $6.6 million from $8 million year over year, fully attributable to the wind-down of non-core SMB business.
Managed Services bookings fell $1.2 million year over year, including a $1 million timing impact from enterprise accounts.
Gross margins remained stable, supported by consistent cost of revenue despite revenue pressures.
Operating expenses decreased 3% year over year to $4.1 million, driven by lower sales and marketing costs offset partially by higher G&A.
The company posted a net loss of $800 thousand (-$0.04 per share), widening from a loss of $100 thousand (-$0.01 per share) in the prior year period, despite cost reductions.

View recap

Kayne Anderson BDC, Inc.

KBDC Q1 2026

Reported: 2026-05-13

Shares of Kayne Anderson BDC rose 3.8% following a quarter that demonstrated resilient income generation and disciplined capital deployment. The market appears to reward KBDC’s conservative portfolio positioning and robust dividend coverage amid ongoing sector headwinds and rising nonaccruals.

Key takeaways

Net investment income was $0.43 per share, covering the $0.40 dividend at 108%, down slightly from $0.44 in Q4 2025.
Net asset value per share declined 0.55% to $16.23, reflecting modest portfolio markdowns partly offset by origination activity and share repurchases.
Nonaccrual investments increased to 2.5% of the portfolio from 1.4% the prior quarter, with two new companies added and one removed from nonaccrual status.
New private credit commitments totaled $93 million with total fundings of $99.1 million; pricing for new floating rate loans widened by 20 basis points over SOFR to 549 bps.
Liquidity remained strong at $569.7 million, supported by $32.7 million in cash and $537 million in undrawn credit capacity, positioning the company well for tactical opportunities.

View recap

Gladstone Land Corporation

LAND Q1 2026

Reported: 2026-05-13

Gladstone Land’s stock was essentially unchanged, reflecting a mixed quarter with stable portfolio metrics but ongoing lease modifications and tenant challenges weighing on near-term visibility.

Key takeaways

The company manages about 99,000 acres across 144 farms in 14 states, with significant water assets concentrated in California.
No acquisitions or sales occurred this quarter, although management may pursue farm sales to reduce debt and repurchase preferred stock.
Modified lease structures continue impacting revenue recognition, with increased risk sharing amid challenging market conditions in permanent crops like nuts and wine grapes.
Eight farms remain partially or wholly vacant, and four tenants are on cash basis revenue recognition, including two new delinquencies this quarter.
The 2025 harvest exceeded initial yield forecasts, particularly in almonds and pistachios, but 2026 faces uncertainty given weather-induced crop stress and the pistachio alternate bearing cycle.

View recap

Leatt Corporation

LEAT Q1 2026

Reported: 2026-05-13

Leatt's shares jumped 23.9% following a first quarter marked by broad-based revenue and income growth, driven by accelerating global demand, strong consumer direct sales, and stable gross margins.

Key takeaways

Q1 2026 revenues reached $19.5 million, up 27% year-over-year, led by a 59% increase in helmet sales and 25% growth in body armor.
Consumer Direct sales surged 49%, highlighting robust brand momentum and direct engagement with riders.
Net income grew 58% to $1.77 million, supported by a stable gross profit margin at 44%.
Operating cash flow generated $4.55 million, increasing cash on hand by 30% to $17.2 million and maintaining liquidity for growth investments.
Management reaffirmed confidence in the business with continuation of a $750 thousand share repurchase program amid ongoing investments in emerging markets and product development.

View recap

Ramaco Resources, Inc.

METC Q1 2026

Reported: 2026-05-13

Ramaco Resources’ shares rose 8.8% after earnings, reflecting investor approval of ongoing cost discipline, share repurchase activity, and early signs of supply tightening in coal markets despite continued top-line challenges.

Key takeaways

The company repurchased approximately 2.6 million shares year-to-date at an average price of $14.50, representing about 5% of shares outstanding, signaling confidence in intrinsic value relative to market valuation.
Cash costs remained below $100 per ton for the third consecutive quarter, achieved amid rising diesel prices that added roughly $4 per ton in cost compared to early 2026 levels.
Coal pricing remains weak, particularly for high-vol products, but emerging production cutbacks and bankruptcies suggest a potential supply-demand inflection going forward.
Growth initiatives focus on low-vol coal, with restarted and expanded mining sections expected to add up to 0.5 million tons in 2027, supported by infrastructure investments like a new rail loadout to reduce trucking costs by about $20 per ton.
Progress continues on rare earth and critical mineral projects, with key technical studies expected in the second half of the year and ongoing discussions with potential offtake and financing partners.

View recap

Neo Performance Materials Inc.

NEO.TO Q1 2026

Reported: 2026-05-13

Neo Performance Materials’ shares jumped 8.3% following Q1 results that far outpaced expectations, driven by record adjusted EBITDA and robust pricing in their Rare Metals segment. The company also raised its full-year adjusted EBITDA guidance significantly, reflecting sustained momentum across all three business units.

Key takeaways

Q1 revenue reached $155 million, a 27% increase year-over-year.
Adjusted EBITDA more than doubled to $36.2 million from $17.1 million in Q1 2025, marking the highest quarterly EBITDA in company history.
Rare Metals segment led the performance with record earnings, supported by a continued strong pricing environment for key metals such as hafnium and gallium.
Magnequench business posted a 39% year-over-year increase in adjusted EBITDA, driven by higher demand for bonded magnets and powders.
Raised full-year adjusted EBITDA guidance to $100 million–$110 million, up from $75 million–$80 million previously, underpinned by continued resilient demand and recent upticks in contract volumes.

View recap

Novanta Inc.

NOVT Q1 2026

Reported: 2026-05-13

Novanta's Q1 results displayed notable revenue and bookings beats, driving an 11% stock gain as underlying demand across advanced surgery, robotics, and precision manufacturing showed clear acceleration.

Key takeaways

Reported revenue grew 10% year-over-year with 3% organic growth, accelerating from the prior quarter.
Bookings surged 37% year-over-year, yielding a book-to-bill ratio of 1.10, indicating ongoing momentum.
Adjusted EBITDA increased 14%, with margin expansion of 70 basis points, alongside a 9% rise in adjusted diluted EPS.
Operating cash flow rose 63% year-over-year, with cash flow conversion exceeding 200% of net income.
Double-digit growth persisted in Advanced Surgery and medical consumables; Robotics & Automation bookings jumped 50%, and Precision Manufacturing returned to mid-single-digit revenue growth.

View recap

Nextracker Inc. Class A Common Stock

NXT Q4 2026

Reported: 2026-05-13

NextPower’s shares declined modestly by 0.7% following earnings, reflecting a mixed reaction to solid bookings and revenue growth tempered by near-term margin pressures related to ongoing investments and cautious outlook commentary.

Key takeaways

Revenue increased 20% year-over-year, driven by strength in the core tracker business and record backlog exceeding $5.25 billion.
The company reported one of its highest booking quarters historically, with bookings weighted 79% in the U.S. and 21% internationally.
Strategic investments in power conversion technology and a pending acquisition are expected to pressure near-term profitability but support accelerated growth starting next year.
Management highlighted sustained demand driven by growing global electricity needs and structural market tailwinds for solar combined with storage.
The firm expressed confidence in exceeding its previously disclosed 2030 revenue outlook despite short-term modeling impacts from innovation expenditures.

View recap

Nayax Ltd

NYAX Q1 2026

Reported: 2026-05-13

Nayax shares rose 3.3% following Q1 2026 results that showed solid revenue growth and margin expansion, driven by strength in hardware sales and transaction volumes across high-value verticals.

Key takeaways

Revenue increased 32% to $107 million, with organic growth of 26%.
Adjusted EBITDA margin expanded to 13%, underscoring ongoing margin improvement.
Installed base surpassed 1.5 million devices, supporting a recurring revenue model that grew 27% and accounted for 74% of total revenue.
Total transaction value rose 33% to approximately $1.8 billion, fueled by growing penetration in EV charging, amusement, and car wash segments.
Hardware sales jumped 46%, boosted by demand for new PIN-on-glass VPOS Media devices in Europe and strategic moves in Brazil.

View recap

Oklo Inc.

OKLO Q1 2026

Reported: 2026-05-13

Oklo's shares dropped 5.8% post-earnings as cautious execution updates and an implied deceleration in near-term revenue recognition raised investor concerns despite strategic progress and a strengthened balance sheet.

Key takeaways

The company highlighted significant progress on its Aurora powerhouses and regulatory approvals, yet concrete commercialization milestones remain in early stages.
Momentum around licensing reforms (NRC Part 57 and Part 53) supports Oklo's fleet deployment model but does not translate into immediate revenue or operational results.
Strong emphasis on building infrastructure for fuel fabrication, recycling, and isotope production suggests a long runway but limited current cash flow generation.
Customer pipeline growth with key partners like Switch and Meta acknowledged, though no new binding contracts or near-term deployments were announced.
The balance sheet was strengthened to support deployment and long-term growth, reflecting ongoing capital needs for execution rather than profitability.

View recap

On Holding AG

ONON Q1 2026

Reported: 2026-05-13

On Holding's stock declined modestly by 0.6% following Q1 results as investors digested strong top-line growth offset by limited commentary on margin sustainability and no clear guidance updates, leaving uncertainty around near-term outlook and margin trajectory.

Key takeaways

Net sales surpassed CHF 830 million, marking a 26.4% increase at constant currency and crossing the CHF 800 million threshold for the first time.
Growth was broad-based with double-digit constant currency increases in the Americas, EMEA, and APAC, and over 50% growth in apparel globally.
The company highlighted early commercial traction for LightSpray technology, contributing close to 20% of footwear net sales at the Boston store launch.
Adjusted EBITDA and gross profit margins were described as strong, but no quantitative updates were provided on margin trends or guidance.
The call focused heavily on innovation and brand momentum without providing new forward-looking financial targets, which may have fed investor caution.

View recap

Plug Power Inc.

PLUG Q1 2026

Reported: 2026-05-13

Plug Power’s 14.1% stock jump reflects strong revenue growth and substantial gross margin improvement, driven by accelerating electrolyzer sales and material handling demand, which together outpaced cautious full-year guidance.

Key takeaways

Revenue rose 22% year-over-year to $163.5 million, led by a 343% surge in electrolyzer sales ($40.8 million) and 15% growth in material handling.
Gross margin improved sharply from -55% to -13%, a 42-point gain driven by Project Quantum Leap cost reductions and operating leverage.
Hydrogen fuel sales grew 10%, with margin gains of 54 percentage points reflecting better plant utilization and logistics.
Management maintained 2026 sales growth guidance of 13–15%, signaling a moderation after strong Q1 delivery driven partly by program pull-ins.
Cash position remained strong at $802 million total, supported by ongoing asset monetization initiatives expected to unlock over $275 million in 2026.

View recap

D-Wave Quantum Inc.

QBTS Q1 2026

Reported: 2026-05-13

Shares dropped 7.0% after the earnings release, reflecting investor disappointment with the cautious outlook and lack of clear near-term commercial traction despite management’s optimistic narrative around technology differentiation.

Key takeaways

The company emphasized its dual rail qubit technology as a revolutionary development, aiming to combine speed and efficiency advantages over other quantum modalities.
Management highlighted a large total addressable market ($800 billion) and a $100-$220 billion optimization market uniquely served by their annealing technology.
Recent acquisition of Quantum Circuits broadens their technology portfolio into gate model quantum computing, claiming a unique full-market participation.
Despite technological advances, there was no detailed update on near-term revenue acceleration or margin improvement, contributing to investor skepticism.
The CEO acknowledged ongoing challenges in delivering practical quantum computing benefits today, underscoring the need for differentiation amid increasing competition and hype in the sector.

View recap

Quantum Computing, Inc.

QUBT Q1 2026

Reported: 2026-05-13

Quantum Computing, Inc. reported a notable 15.7% stock jump as market participants rewarded the company’s substantial revenue growth driven by acquisitions and progress toward scalable quantum manufacturing. The successful integration of Luminar Semiconductor and NuCrypt, alongside early revenue from their foundry operations, reassured investors on commercialization prospects.

Key takeaways

Q1 revenue reached $3.7 million, a significant jump from $39,000 year-over-year, primarily fueled by the recent acquisitions of Luminar Semiconductor and NuCrypt.
Luminar Semiconductor adds vertically integrated photonics capabilities, including manufacturing facilities and government contract exposure, supporting scale-up ambitions.
NuCrypt expands the quantum communications portfolio with patented technology serving defense and research customers.
Early-stage foundry operations at Fab 1 in Tempe, Arizona, are ramping up, generating initial revenue while focusing mainly on R&D.
The company announced plans for Fab 2 to enable higher volume manufacturing, a critical step for long-term scalability in quantum hardware deployment.

View recap

QuickLogic Corporation

QUIK Q1 2026

Reported: 2026-05-13

The stock gained 5.5% following the quarter, reflecting investor optimism around progress in RadPro FPGA development, Intel 18A contracts, and expanding opportunities despite some contract timing delays.

Key takeaways

RadPro FPGA demonstration on GlobalFoundries 12LP process was successful, with multiple development kits shipped, contributing low six-figure revenue in Q2.
Signed a memorandum of understanding with a defense industrial base (DIB) partner to accelerate evaluation of RadPro chiplet applications.
Announced four contracts related to Intel 18A technology, totaling nearly $2 million, laying groundwork for larger future awards.
Timing of a significant commercial Intel 18A contract has shifted from late Q2 to Q3 due to customer-driven scope expansion.
Delivered architectural enhancements from a 1 million LUT feasibility study, expanding addressable markets for high-density eFPGA cores and discrete FPGAs.

View recap

Rigetti Computing Inc. Common Stock

RGTI Q1 2026

Reported: 2026-05-13

Rigetti's shares were essentially unchanged after earnings, reflecting a market verdict that progress on the new 108-qubit system and increasing customer adoption balanced with the absence of a clear catalyst or guidance update.

Key takeaways

Launched general availability of the Cepheus-1-108Q system, a 108-qubit modular quantum computer, now accessible through Rigetti Quantum Cloud Services, Amazon Bracket, Microsoft Azure Quantum, and qBraid.
Achieved median 2-qubit gate fidelity of approximately 99.1% and single qubit gate fidelity of 99.9% on Cepheus-1-108Q, with further improvements expected throughout 2026.
Continued sales growth in on-premises Novera QPU units, including a recent order from the University of Saskatchewan, supporting year-over-year revenue growth.
Highlighted partnerships with leading cloud providers as validation of technology and go-to-market strategy.
No explicit guidance updates or outlook revisions provided during the call.

View recap

Satellogic Inc. Class A Ordinary Shares

SATL Q1 2026

Reported: 2026-05-13

Satellogic's shares dropped 13.2% after the quarter, reflecting investor concerns over cautious outlook elements and margin pressures despite solid revenue growth and operational milestones.

Key takeaways

Revenue grew 80% year-over-year to $6.1 million, driven by international expansion and new product launches.
Adjusted EBITDA loss narrowed by 32% to $4.2 million; however, the company remains unprofitable on this metric.
Positive net cash from operating activities was reported for the first time, signaling improved cash flow management.
The $121.9 million cash balance provides runway, but margin compression and the pace of scaling remain investor concerns.
Strengthened defense engagement with new strategic adviser Vice Admiral Whitworth and a $12 million sovereign defense contract announced.

View recap

Stellus Capital Investment Corporation

SCM Q1 2026

Reported: 2026-05-13

Stellus Capital’s shares declined modestly by 0.8% following a quarter marked by a decline in net asset value driven by realized and unrealized losses on debt investments and elevated nonaccrual loan levels, tempering investor confidence despite stable core income and maintaining dividends.

Key takeaways

Core net investment income was $0.27 per share, with total realized income of $0.29 per share, including $0.75 million in realized gains.
Net asset value decreased by $0.28 per share, primarily due to $0.08 per share of dividends paid in excess of earnings and $0.20 per share of net realized and unrealized losses related mainly to debt investments.
The investment portfolio at fair value declined to $990 million from $1.01 billion, with 117 portfolio companies at quarter-end.
Nonaccrual loans increased to six companies, representing 9.2% of total cost and 5.2% of fair value of the portfolio, higher than desired and a clear risk factor.
Management announced a $20 million share repurchase program at a roughly 25% discount to net asset value, reflecting undervaluation concerns but also uncertain outlook on dividends, which may normalize lower over time.

View recap

Sea Limited

SE Q1 2026

Reported: 2026-05-13

Sea Limited’s stock rose 10.2% following Q1 2026 earnings, driven by better-than-expected revenue growth and margin expansion, particularly from strong monetization gains and improving logistics economics across key markets.

Key takeaways

Revenue surpassed $7 billion, growing 47% year-on-year.
Adjusted EBITDA exceeded $1 billion for the first time, reflecting disciplined cost management amid ongoing growth investments.
Shopee’s GMV grew 30% year-on-year with significant gains in advertising revenue (+80%) and an increased ad take rate (+90 basis points).
Operational efficiencies in logistics, including a 20% reduction in cost per order for instant delivery and expanded fulfillment services, are driving improved unit economics.
Brazil emerged as the fastest-growing and profitable market, supported by broad product assortment and logistics cost advantages.

View recap

Standard Lithium Ltd.

SLI Q1 2026

Reported: 2026-05-13

Shares declined modestly by 1.0% following the quarter, reflecting investor caution despite continued operational progress; the cautious outlook and lack of near-term catalysts tempered enthusiasm.

Key takeaways

Demonstration plant achieved significant operational milestones, processing over 1 million barrels of brine with 95%+ lithium recovery and 99%+ contaminant rejection.
Secured first binding offtake agreement with Trafigura for 8,000 metric tons per year over 10 years, covering 40% of targeted contracted capacity.
Progress underway on critical vendor contracts and NEPA regulatory approval, both expected to conclude in Q2 2026.
Project financing and remaining customer offtake agreements are ongoing, with FID targeted in 2026 to commence construction.
Net loss increased to $2.7 million for Q1 2026 versus $1.6 million in Q1 2025; cost control efforts delivered only marginal reductions in G&A.

View recap

Sleep Number Corporation

SNBR Q1 2026

Reported: 2026-05-13

Sleep Number's shares plunged 27.8% following the earnings release, reflecting investor disappointment primarily with cautious outlook commentary and margin pressures despite early signs of demand improvement. The cautious tone on the turnaround timeline and ongoing capital structure concerns outweighed any operational positives.

Key takeaways

Net sales reached $319 million, roughly in line with expectations, but with a majority of new product sales deferred to Q2 due to late-quarter launches.
Adjusted EBITDA of $6 million slightly exceeded the company’s internal plan but remains modest relative to scale.
Early product resets and new launches show promising signs: stores with the new lineup saw a 12% higher average revenue unit (ARU) and ComfortMode product reduces return rates by 100 bps compared to legacy products.
Management emphasized ongoing macroeconomic headwinds, the need for cautious planning, and incremental near-term liquidity support through an additional $55 million in funding.
Despite product and marketing initiatives, investors remain concerned about overall margin pressures, capital structure risks, and the uncertain pace of sustainable recovery.

View recap

SunPower Corporation

SPWR Q1 2026

Reported: 2026-05-13

SunPower's shares dropped 7% following the Q1 report, as revenue came in 9% below guidance, operating losses widened due to late cost increases, and management provided a cautious near-term outlook with only modest improvement expected in Q2.

Key takeaways

Q1 revenue was $72.8 million, missing the $80 million guidance by 9%, signaling ongoing deceleration.
Non-GAAP operating income was a loss of $12.9 million, pressured by a one-time $9.9 million spending increase not anticipated to recur.
Significant cost-cutting initiatives, including 115 layoffs and a company-wide 4-day workweek (effectively a 20% pay cut), are underway but were implemented too late to impact Q1 results.
Despite recent $41 million capital raise used primarily to pay down debt, the company projects a modest revenue bump to $75 million in Q2 with a reduced operating loss of $3 million.
Management remains cautious, emphasizing recovery tied to acquisitions and expecting profitability only by Q3 with a projected revenue target of $96 million.

View recap

Star Equity Holdings, Inc.

STRR Q1 2026

Reported: 2026-05-13

Star Equity's shares rose 3.3% post-earnings, driven by stronger-than-expected merger synergies and continued growth in its Energy Services division, which helped offset softness in Business Services and Building Solutions.

Key takeaways

Revenue surged 57% year-over-year to $50.1 million, boosted by inclusion of Star operating companies following the August 2025 merger.
Merger synergies of approximately $2.6 million annually surpassed initial $2 million expectations.
Energy Services delivered a strong quarter with market share gains, while Business Services faced challenges from a difficult talent market despite modest revenue and gross profit growth (9.8% and 6.4%, respectively).
Building Solutions underperformed due to delayed contracts and severe winter weather, reporting $11.6 million revenue with $1.6 million gross profit and a $900,000 adjusted EBITDA loss.
Operating cash flow was negative $1.4 million, partly offset by over $3 million from sale-leaseback transactions; the company repurchased $700,000 of stock during the quarter, reflecting confidence in the stock’s valuation.

View recap

T1 Energy Inc

TE Q1 2026

Reported: 2026-05-13

T1 Energy's shares dropped 7.1% after the company issued cautious commentary on demand deceleration and ongoing financing risks related to the G2_Austin solar project, overshadowing operational profitability gains. Investor disappointment appears driven by the tepid market outlook and the unresolved $225 million financing package critical to G2’s completion.

Key takeaways

Adjusted EBITDA reached a record $9.1 million in Q1 2026, driven by improved contract mix favoring cost-plus and fixed margin volumes.
Gross margin expanded to 17%, up about 10 percentage points sequentially, reflecting better pricing versus heavy merchant sales last quarter.
Throughput declined to 683 MW in Q1, indicating demand softness following pre-year-end rushes ahead of regulatory restrictions.
Construction of the 2.1 GW G2_Austin plant remains on schedule for first cell production in Q4 2026, but $225 million of CapEx financing remains unresolved and is a near-term priority.
Market dynamics remain challenging with customers drawing down inventory, pointing to a cautious outlook for sales velocity in the near term despite anticipated second-half shipment increases.

View recap

Mammoth Energy Services, Inc.

TUSK Q1 2026

Reported: 2026-05-13

Mammoth Energy’s stock surged 23% post-earnings, driven by a clear turnaround evidenced by its first positive EBITDA quarter in two years and raised 2026 guidance, signaling that the market is convinced by early operational improvements and disciplined capital allocation.

Key takeaways

Revenue rose 90% year-over-year and 133% sequentially to $22 million, led primarily by the Rentals segment, particularly aviation assets.
Adjusted EBITDA turned positive at $1.9 million, marking the first positive EBITDA quarter in eight quarters.
Management initiated share repurchases, reflecting confidence in the business trajectory.
Sequential SG&A declined approximately 37%, with structural cost reductions reducing annual run rate from ~$25 million in 2024 to a projected $11–12 million.
While Sand and Drilling segments saw revenue gains, margins showed pressure due to higher operating costs and market activity factors, with targeted actions underway to improve efficiencies and profitability.

View recap

Under Armour, Inc.

UA Q4 2026

Reported: 2026-05-13

Under Armour’s shares declined sharply by 16.7% following earnings, reflecting investor disappointment with the cautious outlook and signals of margin pressure despite management’s focus on product premiumization and operational discipline.

Key takeaways

The company is prioritizing a strategic reset focused on fewer, higher-quality products rather than volume growth, signaling constrained near-term upside.
Footwear growth, a key midterm priority, showed signs of inconsistency, with a heavier emphasis now on apparel—Historically the brand's strongest segment.
Management emphasized new product innovation, such as the BANT T-shirt and premiumized apparel, seeking to improve product mix and margins rather than drive unit sales.
Increased operational rigor and financial discipline aim to strengthen profitability, but trade-offs include walking away from nonprofitable business areas.
Despite these initiatives, investors interpreted the commentary as cautious and indicative of margin compression, leading to the sharp sell-off.

View recap

Ulker Biskuvi Sanayi A.S.

ULKER.IS Q1 2026

Reported: 2026-05-13

Ulker Biskuvi’s shares fell 3.2% after Q1 2026 results as investors reacted to the cautious outlook amid a challenging macro environment and structural volume decline in Turkey, despite solid international volume growth and maintained margins.

Key takeaways

Domestic confectionery volumes face structural headwinds, with Turkey’s market declining 2.5% in 2025 and softness continuing into early 2026.
International operations showed strength, delivering 8.8% volume growth despite ongoing geopolitical tensions.
EBITDA margin held at 15.1%, though management flagged timing and inventory effects rather than underlying margin improvement.
Net income was TRY 1.6 billion, reflecting disciplined cost management in a volatile market but no clear growth acceleration.
Guidance and outlook stress quality of growth and cash discipline over top-line expansion, underscoring cautious stance in an inflationary, disinflationary environment impacting consumer demand.

View recap

Uniti Group Inc.

UNIT Q1 2026

Reported: 2026-05-13

Shares declined modestly by 0.5% following Uniti's Q1 2026 earnings as investors weighed solid fiber revenue growth against cautiousness around the high investment spend and incremental operational challenges at Kinetic.

Key takeaways

Total fiber revenue increased 15% year-over-year, driven by 13% growth at Fiber Infrastructure and strong consumer fiber additions at Kinetic.
Kinetic reported the highest gross adds and homes constructed in nearly four years, alongside its best-ever consumer fiber churn rate, reflecting progress on customer retention.
The company continued ramping its fiber-to-the-home build, reaching 45,000 new homes in both March and April, targeting 450,000 to 500,000 new homes in 2026.
Hyperscaler demand remained robust, with bookings at Fiber Infrastructure near all-time highs and lease-up yields at 35%.
Management highlighted 2026 as a critical investment year aimed at long-term growth, but elevated spending suggests margin pressures and cautious outlook may temper near-term returns.

View recap

Upexi Inc. Common Stock

UPXI Q3 2026

Reported: 2026-05-13

Shares dropped 8.2% as the sharp 33% decline in Solana's price during the quarter highlighted continued deceleration and bearish market sentiment, overshadowing management’s efforts on capital initiatives and expense control.

Key takeaways

Solana’s token price fell from approximately $125 to $83, a 33% drop, significantly dragging down valuation multiples amid a weak broader crypto market.
Despite a rebound from an intra-quarter low of 77% to 96%, investor concerns persist regarding near-term price volatility tied to Bitcoin’s downturn.
The company repurchased 2.5 million shares at $0.80 each, below NAV, aiming to increase Solana per share and deployed convertible notes and equity offerings above NAV to strengthen capital structure.
Operating expenses are expected to normalize and be less than treasury staking revenue by mid-2026, reflecting cost restructuring including outsourcing its brand business operations.
Yield generation efforts continue to focus on identifying low-risk, recurring strategies to boost the effective staking yield beyond Solana’s native 7%, but these remain developmental.

View recap

Village Farms International, Inc.

VFF Q1 2026

Reported: 2026-05-13

Village Farms' 1Q26 results beat expectations as total net sales rose 27% year-over-year, driven by a 171% surge in international export sales and sustained price stability in key markets. The 3.9% stock lift reflects investor approval of expanding global cannabis operations and capacity enhancements.

Key takeaways

Total net sales increased 27% year-over-year, with a modest 2% sequential gain despite capacity constraints ahead of planned expansion.
Adjusted EBITDA more than doubled (+118% YoY), supporting the company’s fourth consecutive quarter of positive net income.
International exports reached nearly $15 million, up 171% year-over-year and 60% sequentially, led by growth in Germany where Village Farms holds multiple top cultivars.
Pricing for EU GMP-compliant flower remained stable in international markets, contrasting with broader industry price compression.
Expanded production capacity at the British Columbia facility now positions Village Farms as having the world’s largest EU GMP-certified cannabis operation, reinforcing competitive advantages.

View recap

Vonage Holdings Corp.

VG Q1 2026

Reported: 2026-05-13

Venture Global shares jumped 11.9% following an upbeat quarter marked by a significant upward revision in EBITDA guidance and strong commercial momentum, which reassured investors on growth and contract backlog.

Key takeaways

EBITDA guidance for 2026 was raised sharply from $5.2–5.8 billion to $8.2–8.5 billion, reflecting improved liquefaction fee assumptions.
Long-term contracts now cover 52 MTPA, underpinning approximately $137 billion in revenue backlog and up from 69% contracted in early 2021 to 84% for 2026.
Operational strength demonstrated with a new first-quarter record of 130 cargoes exported and over 150 contracted cargoes delivered on schedule at Calcasieu Pass.
Progress on CP2 Phase 2 remains rapid, with nearly all perimeter wall completed and key liquefaction trains and turbines installed, supporting expectations for fastest-to-market LNG startup.
Capital structure improvements included refinancing of higher-interest preferred securities with more tax-efficient term loan B facilities and issuance of bonds to retire construction debt.

View recap

VI

Via Renewables, Inc.

VIA Q1 2026

Reported: 2026-05-13

Shares dropped 21.4% following earnings as investors reacted negatively to a cautious outlook and indications of margin pressure despite year-over-year revenue growth and customer expansion.

Key takeaways

Revenue increased 29% year-over-year to $127 million, surpassing the $0.5 billion run-rate milestone.
Customer count grew 23% year-over-year to 838, reflecting ongoing platform adoption.
Adjusted EBITDA margin remained negative at -4.6%, highlighting continued margin compression and distance from profitability.
The company emphasized pipeline growth with a record $650 million in opportunities but flagged intensified competition and market challenges impacting outlook.
Recent wins in full transit network management suggest potential but have yet to translate into meaningful margin improvement or commercial scale.

View recap

Vodafone Group Public Limited Company

VOD.L Q4 2026

Reported: 2026-05-13

Shares dropped 4.6% as investors reacted negatively to cautious outlook signals, with concerns likely driven by deceleration in key segments and an unclear growth trajectory despite management’s optimistic framing.

Key takeaways

FY ’26 results met the upper end of guidance with 4.5% organic adjusted EBITDAaL growth and EUR 2.6 billion adjusted free cash flow.
Group service revenue grew 5.1% in Q4, supported by Europe and Africa, including the highest service revenue growth in Africa in nearly two decades.
Germany showed improvement in B2B and consumer broadband despite market pressure, but challenges remain in mobile and TV segments.
UK integration progresses with customer satisfaction gains and broadband expansion, alongside expected cost and CapEx synergies from VodafoneThree acquisition.
Management highlighted a midterm target of double-digit organic free cash flow growth, but market skepticism likely reflects doubts over the timing and sustainability of this outlook.

View recap

Goodness Growth Holdings, Inc.

VREOF Q1 2026

Reported: 2026-05-13

Vireo Growth’s shares rose modestly by 0.8% following Q1 results which showed steady pro forma revenue growth and margin improvements, but market reaction suggests investors are waiting for more decisive progress on integration and operational execution before rewarding the stock more fully.

Key takeaways

Reported GAAP revenue surged 333% year-over-year to $106.2 million, driven by multiple acquisitions closed in recent months.
Pro forma revenue, which includes all acquisitions as if they occurred on January 1, 2026, grew 5% year-over-year to $210.2 million, reflecting moderate organic growth in integrated markets.
Adjusted EBITDA on a pro forma basis increased 29.8% to $42.2 million, with margin expansion to 20.1% of sales from 16.2% last year.
Gross margin, excluding non-cash inventory fair value adjustments, improved by 280 basis points to 56.3%.
Company ended Q1 with a strong cash position of $137.8 million and $240 million in current assets versus $82 million in current liabilities, supporting ongoing M&A and investment plans.

View recap

Zebra Technologies Corporation

ZBRA Q1 2026

Reported: 2026-05-13

Zebra Technologies’ shares surged 11.4% following a solid quarter driven by better-than-expected sales growth, margin expansion, and an upbeat outlook supported by strong demand and operational execution.

Key takeaways

Reported sales of nearly $1.5 billion, up 14% year-over-year and 4% organically, signaling sustained demand across segments and geographies.
Adjusted EBITDA margin expanded 90 basis points to 23.2%, reflecting a multiyear high gross margin and effective operating expense leverage.
Non-GAAP diluted EPS increased 18% to $4.75, highlighting profitable growth.
Strong cash flow generation enabled $500 million in share repurchases year-to-date, underscoring financial strength and capital return discipline.
Management raised full-year guidance, citing momentum in demand and progress navigating supply constraints.

View recap

Earnings Recaps

AbCellera Biologics Inc.

AECOM

First Majestic Silver Corp.

Adecoagro S.A.

a.k.a. Brands Holding Corp.

Amentum Holdings, Inc.

Aramark

Arvinas, Inc.

Astronics Corporation

Camtek Ltd.

Consolidated Water Co. Ltd.

Danaos Corporation

Ducommun Incorporated

3D Systems Corporation

Electromed, Inc.

eToro Group Ltd.

Figure Technology Solutions, Inc. Class A Common Stock

Fold Holdings Inc

Fractyl Health, Inc. Common Stock

Hims & Hers Health, Inc.

NIC Inc.

Harrow Health, Inc.

HUYA Inc.

Imperial Brands PLC

Imunon Inc. Common Stock

IZEA Worldwide, Inc.

Kayne Anderson BDC, Inc.

Gladstone Land Corporation

Leatt Corporation

Ramaco Resources, Inc.

Neo Performance Materials Inc.

Novanta Inc.

Nextracker Inc. Class A Common Stock

Nayax Ltd

Oklo Inc.

On Holding AG

Plug Power Inc.

D-Wave Quantum Inc.

Quantum Computing, Inc.

QuickLogic Corporation

Rigetti Computing Inc. Common Stock

Satellogic Inc. Class A Ordinary Shares

Stellus Capital Investment Corporation

Sea Limited

Standard Lithium Ltd.

Sleep Number Corporation

SunPower Corporation

Star Equity Holdings, Inc.

T1 Energy Inc

Mammoth Energy Services, Inc.

Under Armour, Inc.

Ulker Biskuvi Sanayi A.S.

Uniti Group Inc.

Upexi Inc. Common Stock

Village Farms International, Inc.

Vonage Holdings Corp.

Via Renewables, Inc.

Vodafone Group Public Limited Company

Goodness Growth Holdings, Inc.

Zebra Technologies Corporation

Community

Trending This Week

Notifications